{
    "organizations": [],
    "uuid": "d4395012ee2cb52ba735b1f3e47e3827c09c850c",
    "author": "",
    "url": "https://www.reuters.com/article/brief-biostar-announces-receipt-of-nasda/brief-biostar-announces-receipt-of-nasdaq-continued-listing-deficiency-notice-idUSFWN1S013R",
    "ord_in_thread": 0,
    "title": "BRIEF-Biostar Announces Receipt Of Nasdaq Continued Listing Deficiency Notice",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 23, 2018 / 8:32 PM / Updated 10 minutes ago BRIEF-Biostar Announces Receipt Of Nasdaq Continued Listing Deficiency Notice Reuters Staff 1 Min Read \n  Biostar Pharmaceuticals Inc: \n* BIOSTAR ANNOUNCES RECEIPT OF NASDAQ CONTINUED LISTING DEFICIENCY NOTICE Source text for Eikon: Further company coverage:",
    "published": "2018-04-23T23:32:00.000+03:00",
    "crawled": "2018-04-23T23:52:43.137+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "announces",
        "receipt",
        "nasdaq",
        "continued",
        "listing",
        "deficiency",
        "notice",
        "reuters",
        "staff",
        "min",
        "read",
        "biostar",
        "pharmaceutical",
        "inc",
        "biostar",
        "announces",
        "receipt",
        "nasdaq",
        "continued",
        "listing",
        "deficiency",
        "notice",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}